Skip to main content
See every side of every news story
Published • loading... • Updated

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Consensus Target Price of $706.87

Summary by MarketBeat
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) has received an average rating of "Moderate Buy" from the seventeen analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommenda

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Saturday, November 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal